News and Events

29
2026-04
Infographic | ClinPlus 2025 Environmental, Social and Governance Report
29
2026-04
Infographic | ClinPlus 2025 Annual Report and 2026 First Quarter Report
05
2026-02
ClinPlus Named a "Model Case of New Quality Productive Forces in Industrial Practice"; Ruixing System Empowers Drug R&D
05
2026-02
ClinPlus's "Ruixing Clinical Trial Text Generation Algorithm" Filed with the Cyberspace Administration of China
05
2026-02
ClinPlus Charity Farming Initiative: A Win-Win for Rural Industry and Employee Welfare
05
2026-02
Another Honor | ClinPlus Wins Multiple Awards from the China Association for Public Companies, Including "Best Practice Case for Listed Company Board Office" and "5A Rating for Board Secretary Performance"
29
2025-10
Quick Overview | ClinPlus 2025 Q3 Report Highlights
Strengthening the Foundation, Advancing Steadily
03
2025-11
Good News | ClinPlus Receives "A" Rating in Shenzhen Stock Exchange Information Disclosure Assessment for the First Time
09
2025-10
Warmth for the Borderlands: ClinPlus Scholarship Program Helps Students Pursue Their Dreams
09
2025-10
"China Innovative Drug Decade Honor List" Announced: ClinPlus Wins "Industry-Leading CRO Company" Award
09
2025-10
ClinPlus Subsidiary Officially Moves into the International Clinical CRO Industry Center in Wuhou District, Chengdu
09
2025-10
Media Interview | From Clinical Trial Stereotypes to 30,000 Thank-You Letters a Year: Helping Novel Therapies Reach Trial Participants Faster
28
2025-08
ClinPlus 2025 Interim Report | New Orders Up 40.12% Year-on-Year; SMO Operations Steady and Improving
15
2025-07
ClinPlus Moves into West China Translational Medicine Industrial Park to Deepen Its Clinical Research Service Ecosystem
15
2025-07
ClinPlus Recognized as a 2025 Shanghai "Specialized, Refined, Differentiated and Innovative" SME (First Batch)
19
2025-05
2025 ClinPlus Clinical Trial Site Inspection Experience-Sharing Session (Beijing) Concludes Successfully
30
2025-04
Infographic | ClinPlus 2024 Environmental, Social and Governance Report
30
2025-04
Infographic | ClinPlus 2024 Annual Report
28
2025-03
Capital Market Leadership Training Program Delegation Visits ClinPlus: Focus on New Opportunities in Biopharmaceutical Innovation and Digital Development
14
2025-03
Books for Xinjiang: ClinPlus Donated Library Brightens Borderland Childhoods at the Start of the School Year
26
2025-02
ClinPlus Inspection Assistance Services
26
2025-02
ClinPlus Third-Party Quality Control and Audit Services
26
2025-02
Introduction to ClinPlus Inspection Meeting Services
17
2025-01
2024: 30,986 Stories That Belong to ClinPlus
31
2024-12
2024 in Review | Strengthening Capabilities, Driving Innovation
02
2024-12
ClinPlus Wins "2024 Best Practice Case for Sustainable Development of Listed Companies"
13
2024-11
ClinPlus Officially Launches "Rui Zhi Jia", Its Patient Service Brand
04
2024-11
Business in Detail | ClinPlus Inspection Assistance Services
29
2024-10
Quick Overview | ClinPlus 2024 Q3 Report Highlights
29
2024-10
ClinPlus Honored with the "Golden Information Disclosure Award" at the 26th Golden Bull Awards for Listed Companies
29
2024-08
Quick Overview | ClinPlus 2024 Interim Report
23
2024-08
SSU Case Study | 28 Sites Activated in Three Months
26
2024-07
Huangpu District People's Congress Standing Committee Delegation Visits ClinPlus
16
2024-07
ClinPlus Clinical Trial Site Inspection Experience-Sharing Session Held Successfully
14
2024-06
Wind ESG Rating Upgraded to A: ClinPlus (301257.SZ) Opens a New Chapter in Sustainable Development
30
2024-04
Infographic | ClinPlus 2023 Environmental, Social and Governance Report
08
2024-05
ClinPlus Granted a National Invention Patent
28
2024-04
Infographic | ClinPlus 2023 Annual Report
04
2024-01
2023 in Review | Staying Pragmatic and Innovative, Moving Forward with Courage
21
2023-12
Two Numbers That Warmed ClinPlus This Winter
24
2023-11
ClinPlus Signs with Xiamen Haicang District to Boost Biopharmaceutical Industry Development
24
2023-11
Chen Ying, Party Secretary and Director of the Huangpu District Tax Bureau, Visits ClinPlus
29
2023-10
Net Profit Tops RMB 100 Million: ClinPlus Sustains Rapid Growth in the First Three Quarters of 2023
26
2023-10
Business in Detail | Introduction to ClinPlus SSU Services
08
2023-10
ClinPlus Clinical Trial Execution Strategy Modeling Services
08
2023-10
Government and Business United | Shanghai Private Enterprises Forum: Stabilizing Expectations, Strengthening Confidence, Expanding Investment, Seeking Development
08
2023-10
Government and Business United | ClinPlus Wins "Annual Leap Award" from Dapuqiao Subdistrict, Huangpu District
08
2023-10
How Are Medicines Created? ClinPlus Public Science Event Visits the Community
28
2023-08
Infographic | ClinPlus 2023 Interim Report
08
2023-08
Passing On Love | ClinPlus Donated Supplies Rush-Delivered to Zhuozhou
13
2023-07
ClinPlus Named Among TOP 10 Most Influential CRO Companies on the "2023 China Biopharmaceutical Industry Value List"
04
2023-07
Wenhui Daily | Driving High-Quality Economic Development — What Is This SMO Company Doing to Advance Innovative Drug R&D?
04
2023-07
Hong Kong Commercial Daily | [Medicine Illuminates China] ClinPlus Innovates Its Clinical Trial Management Model to Advance High-Quality Pharmaceutical R&D
04
2023-07
Economic Information Daily | ClinPlus Advances Innovation and Internationalization of China's Pharmaceutical R&D
04
2023-07
"Driving High-Quality Economic Development" — Chinese and Foreign Media Delegation from the Shanghai Municipal Government Information Office Visits ClinPlus
26
2023-04
Infographic | ClinPlus 2022 Annual Report
09
2023-01
Grateful for the Journey with ClinPlus in 2022; Looking Forward to a New Chapter in 2023
20
2022-12
Zhili Dialogue · ClinPlus | Cultivating the Field of Medical Innovation → Wellness for All, Hearts in Bloom
The "Enterprise Tour · Zhili Dialogue" program of the Zhangjiang Huangpu Park Enterprise Service Center visits ClinPlus to share its story of quietly cultivating the field of medical innovation.
20
2022-12
ClinPlus Invited to the Biopharmaceutical Session of the Huangpu District Online Job Fair
Multiple Open Positions Announced On Site
17
2022-05
Thank You for This Beam of Light That Shines on Us
— In Tribute to Every Devoted Clinical Trial Practitioner
17
2022-05
Wellness for All, Hearts in Bloom | ClinPlus Lists on ChiNext of the Shenzhen Stock Exchange
Following Its Initial Public Offering, the Company Was Officially Listed on the Shenzhen Stock Exchange Today
16
2022-05
ClinPlus to Officially Debut on ChiNext of the Shenzhen Stock Exchange